Mobile Healthcare Services & Medical Transportation
Strategic Profile
DocGo is in a critical transition phase, pivoting from reliance on large government contracts to scaling its core Mobile Health and Medical Transportation services, with future outlook hinging on successfully executing this shift to higher-margin recurring payer and provider partnerships. Core revenue, excluding wind-down projects, grew 8% in Q3 2025, with critical care gap closure services growing 320% year-over-year.
Cyborg Score Rationale
2025 marks a transitional period with a deliberate shift away from volatile government contracts, with full-year revenue guided between $315-320 million due to migrant program wind-down. The company has faced significant operational challenges including contract losses, reflected in an 85% stock decline over the past year. Core operations show growth but execution risk remains high.
Top Insights
2026 guidance projects revenue of $280-300 million with no migrant-related revenue and narrower adjusted EBITDA loss of $15-25 million.
Company acquired PTI Health in 2025 and laid off 360 employees in March 2025 as it exited migrant care space.
DocGo generates revenue through per-transport fees from payors, subscription-based remote monitoring, and government agreements, relying on labor arbitrage and route density optimization.
As government contracts concluded, the company shifted focus to agreements with insurers, healthcare providers, and transportation partners.
Named Competitors
Telehealth & Virtual Care Platform — Virtual care services
Mobile Healthcare & Transportation — Regional ambulance and medical transport
Integrated Healthcare Systems — Insurance provider mobile health programs
Recent Developments
(March 2025) Exited migrant care space with 360 employee layoffs
(2025) Acquired PTI Health mobile lab collection service